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Abstract
Background: The occurrence of tubal ectopic pregnancy (tEP) is related to the inflammation of the oviduct.
Recently, Adrenomedullin (ADM) was found highly expression in human oviduct. The current study is to investigate
whether ADM have a modulatory action on inflammatory cytokines and chemokines in oviductal tissue from
women with tubal ectopic pregnancy (tEP).
Methods: Oviductal isthmus samples were collected from women with tEP undergoing salpingectomy, and
women undergoing hysterectomy for benign gynaecological conditions. The mRNA and protein levels of
inflammatory cytokines/chemokines were assayed by PCR (n = 6 for tEP, n = 5 for controls) and protein microarray
methods (n = 5 for both tEP and controls) respectively.
Results: Some of the inflammatory cytokines/chemokines were upregulated by ADM in oviducts from tEP patients
at both mRNA and protein levels. Incubation of oviduct from tEP patients with ADM for 24 h down-regulated some
of these cytokines/chemokines.
Conclusion: Our results suggest an additional mechanism whereby ADM insufficiency may increase the
susceptibility to tEP through diminished anti-inflammatory activity. The actual impact of the relationship between
ADM and inflammatory process on tubal implantation needs further exploration.
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Background
Tubal ectopic pregnancy (tEP) occurs when an embryo
implants in the oviduct. This is a major life-threatening
health issue but the underlying causes remain unclear.
Adrenomedullin (ADM) is a peptide hormone abundantly
expressed in the human oviduct [1]. Recent studies in our
laboratory showed that the oviduct produced a significant
amount of ADM and the ADM level was highest in the
isthmic region in a hormonal environment simulating the
early luteal phase [1]. A lower ADM expression found in
the oviducts from tEP caused a decrease in ciliary beating
frequency [2, 3] and contraction [2] to impair oviductal
transport of embryos, leading to embryo retention in the
oviduct. As the retention of blastocysts in the oviduct [4]
and haploinsufficency for ADM [5] does not result in tEP
in the mouse, our observations suggest that there may be
other concomitant alterations in the human oviducts, not
present in animal models, to permit implantation at the
ectopic site.
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Implantation requires regulated local expression of
pro- and anti-inflammatory cytokines, chemokines, adhe-
sion molecules and angiogenic factors [6], and involves a
series of events including a change from an initial pro-
inflammatory environment to an anti-inflammatory one.
Proinflammatory cytokines and chemokines, as well as an-
giogenic factors, were induced by trophoblasts in the
endometrium to facilitate implantation [7]. Cytokines, par-
ticularly those in the IL-6 family, play a significant role in
establishing a pro-implantation environment in the uterus
[8]. On the other hand, anti-inflammatory mediators are
important at a later stage of implantation. . For instance,
IL-10 and adiponectin are required to reduce inflamma-
tion and to promote fetal and placental growth [9].
Epidemiological studies indicate that pelvic infection is
the major risk factor for tEP [10] and pelvic inflammatory
diseases account for 20–40 % of all cases of tEP in the
United Kingdom [11]. Chlamydia trachomatis remains
one of the most common pathogens in pelvic infections.
C. trachomatis infection is usually asymptomatic and in
the upper reproductive tract it can predispose the patient
to tEP [12]. Other than C. trachomatis, pelvic inflamma-
tory disease can be caused by Neisseria gonorrhoeae and
anaerobic and mycoplasmal bacteria [13], leading to se-
vere tubal damage, ectopic pregnancy, infertility and
hydrosalpinx [14].
ADM has well-known anti-inflammatory actions [15]
and its level is increased in a coordinated fashion in ex-
perimental and clinical conditions of inflammation and
sepsis [16]. It reduces the production of pro-inflammatory
cytokines including interferon (IFN)-gamma [17, 18] and
various chemokines [19]. Therefore, we hypothesize that
the decrease of oviductal ADM level may contribute to
the pathogenesis of tEP by rendering the tubal environ-
ment more susceptible to inflammation, which then favors
embryo implantation in the oviduct. This is in addition to
another mechanism of action of ADM on pathogenesis of
tEP proposed earlier by us, namely, impairment in ovi-
ductal transport of the embryo [2].
The objectives of this study was to find out whether
the reduction of ADM expression in tEP is related to the
changes in the inflammatory environment by studying
the effect of ADM on the expression profile of inflam-
matory cytokines and chemokines in the oviducts with
ectopic pregnancy. Such data are as yet not available in
the literature.
Methods
Subject recruitment and sample collection
The isthmic parts of oviducts were collected from
women undergoing hysterectomy for benign gynaeco-
logical diseases not involving the oviduct (control group;
median age 50 years, range 45–54 years), as well as
women undergoing salpingectomy for tEP not involving
the isthmic part (median age 32 years, range 25–39
years, mean gestational age 7.3 ± 0.3 weeks), at Queen
Mary Hospital, Hong Kong. Subjects with suspected or
confirmed malignancy or pelvic infection were excluded.
Those with tEP found involving the isthmic region were
also excluded intraoperatively as the whole specimen
would be sent for histopathological diagnosis. In the
absence of oviduct samples from normal pregnancy
women due to ethical reason, the tissues obtained by
hysterectomy were used as controls after priming with
10000 IU/L hCG, 4000 pmol/L estradiol and 50 nmol/L
progesterone for 16 h to simulate the hormone environ-
ment of first trimester pregnancy, as reported in a previ-
ous study [2]. All recruited subjects had not received any
hormonal treatment within 3 months prior to surgery.
Ethics, consents and permissions
Ethics approval was obtained from the Institutional Re-
view Board of the University of Hong Kong/Hospital
Authority Hong Kong West Cluster. Written consent
was sought from the subjects during pre-operative
counseling.
Tissue preparation
After collection, the oviductal tissue was immersed in
ice-cold DMEM/F12 with 10 % FBS (Invitrogen, Carlsbad,
CA) and processed in the laboratory within 24 h. After
washing several times in DMEM/F12 culture medium to
remove all visible blood, the oviducts were incubated in
estradiol, progesterone and human chorionic gonado-
tropin (hCG) for use as controls as described above. To
study the effect of ADM, the oviducts from patients with
tEP were incubated with 100 nM ADM (the dose used in
our previous functional studies, [1, 2, 20–22] for 24 h. The
mRNA expression of five selected genes in the oviductal
tissues from the control group and the tEP groups with
and without ADM treatment were determined by real-
time quantitative PCR, and the protein expression of in-
flammatory cytokines/chemokines were measured by a
cytokine microarray method as detailed below.
Measurement of gene expression of inflammatory
cytokines/chemokines and their receptors by PCR
microarray method
Total RNA was extracted from the oviducts of normal
control (n = 5) and those from tEP (n = 6) with or with-
out ADM treatment using TRIZOL reagent (Invitrogen,
Carlsbad, CA), and was then purified using the Qiagen
RNeasy Mini Kit. Purity of the RNA samples was con-
firmed by an A260/A280 ratio between 1.8 and 2.0 on
an UV spectrophotometer. Genomic DNA was removed
by incubating with an elimination mixture (DNase I, 5x
gDNA elimination buffer) at 42 °C for 5 min. Reverse
transcription was performed using the RT2 first strand
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Kit (Sabioscience company) according to the package in-
sert. Real time PCR was performed for five selected
genes (GM-CSF, IL-2, IFN-gamma, ENA78 and MIG)
using the iCycler ™ (Bio-Rad Laboratories, Hercules, CA,
USA) under the following conditions: 95 °C for 10 min
for initial activation, followed by 40 cycles of denaturation
at 95 °C for 30s, annealing at 57 °C for 30s, and extension
at 72 °C for 30s. G6PDH was used as the housekeeping
gene. The mRNA expression of the studied genes was
quantitated by the 2-ddCt method. The primers used were
as follows:
GM-CSF (NM_000758): Forward 5’ CACTGCTGCTG
AGATGAATGAAA 3’, Reverse 5’ GTCTGTAGGCAG
GTCGGCTC 3’;
IL-2 (NM_000586): Forward 5′ CATTGCACTAAGT
CTTGCACTTGTCA 3′, Reverse 5′ CGTTGATATTGC
TGATTAAGTCCCTC 3′;
IFN-gamma(NM_000619): Forward 5’ TCCCATGGG
TTGTGTGTTTA 3’, Reverse 5’ AAGCACCAGGCATG
AAATCT 3’;
ENA78 (NM_002994): Forward 5’ TGGACGGTGGAA
ACAAGG3’, Reverse 5’CTTCCCTGGGTTCAGAGAC 3’;
MIG (NM_002416): Forward 5’GCATCATCTTGCT
GGTTCTGATTGG 3’; Reverse 5’GCGACCCTTTCTC
ACTACTGGGGT 3’.
G6PDH (NM_000402): Forward 5′-ATC GAC CAC
TAC CTG GGC AA-3′; Reverse 5′-TTC TGC ATC ACG
TCC CGG A-3′.
The five studied genes were selected as representative
members of proinflammatory cytokines and chemokines.
Measurement of cytokine/chemokine protein expression
by antibody array method
Upon confirming the differential mRNA expression of
the representative pro-inflammatory cytokines and che-
mokines in tEP versus controls and the modulating ef-
fect of ADM, we further studied the cytokine/chemokine
expression at the protein level using the RayBio Human
Cytokine Antibody Array C5 (RayBiotech, Inc. GA), which
detected 80 human cytokines/chemokines (Additional
file 1: Table S1). Briefly, the protein of the samples
(control: n = 5; tEP: n = 5) was extracted using the 2X Ray-
Bio Cell Lysis Buffer. After centrifugation, the supernatant
was collected and the protein concentration was measured
using Protein Assay Reagent (BioRad, Hercules, CA). The
protein sample (200 μg) was transferred to an antibody-
array membrane by electroplotting. The antibody-array
membrane was blocked using 1x blocking buffer for
30 min at room temperature. After 3 washes, the mem-
brane was incubated with 2 ml biotin-conjugated anti-
cytokine antibodies for 2 h at room temperature. Then,
2 ml of 1000-fold diluted horseradish peroxidase (HRP)-
conjugated streptavidin was added and incubated for 2 h
to allow the streptavidin to attach to the biotin. After
washing, the membrane was treated with the detection
buffer for HRP for 2 min. After the excess detection buf-
fer had been drained off, the membrane was covered by
two pieces of plastic sheets before exposure to X-ray
film to develop the signals. The intensities of the dot
signals were calculated using the Image J software.
Statistics
The relative mRNA and protein expressions of inflam-
matory cytokines and chemokines were compared be-
tween control and tEP samples using Mann–Whitney U
test, and those between tEP samples with and without
ADM treatment were compared using Wilcoxon signed
rank test. Statistical analysis was carried out using the
IBM SPSS Statistics 20 software (IBM Corporation, New
York, USA). A P value of <0.05 was taken to indicate
statistical significance.
Results
Effect of ADM treatment on mRNA expression of selected
cytokines/chemokines
The mRNA expression of 5 selected inflammatory cyto-
kine/chemokine genes, namely GM-CSF, IL-2, IFN-gamma,
ENA-78 and MIG, was compared between tEP versus
control oviductal tissue, as well as in tEP oviductal tis-
sue with and without ADM treatment, as shown in
Fig. 1. Statistically significant up-regulation of mRNA
expression (p < 0.05) in tEP compared to control was
evident in only 2 of the 5 studied genes, namely GM-
CSF and IFN-gamma although an apparently increased
expression of the rest was seen. Upon ADM treatment
in the tEP tissue, significant lowering of mRNA expres-
sion to a level similar to the non-tEP control was found
in 4 of the 5 studied genes, namely GM-CSF, IL-2, IFN-
gamma and ENA-78 (p < 0.05).
Differential cytokine/chemokine expression at protein
level in tEP oviducts as compared to control oviducts
Eight of the cytokines studied for their protein expres-
sion significantly increased in tEP oviducts compared to
control are listed in Table 1. Four of these (GM-CSF, IL-7,
IFN-gamma and TNF-beta) were pro-inflammatory cyto-
kines, two (IL-10 and HGF) were anti-inflammatory cyto-
kines and two (IL-4 and IL-6) could have either pro- and
anti-inflammatory properties under different pathophysio-
logical conditions [23].
ADM treatment modulates the cytokine/chemokine
expression in tEP oviducts
ADM treatment for 24 h significantly (P < 0.05) reduced
the levels of 7 out of the 8 cytokines that were upregu-
lated in tEP (Table 1), except for IFN-gamma. Another
four pro-inflammatory cytokines (IL-1β, IL-3, IL-8 and
VEGF) and seven chemokines (GRO-α, MCP-1, MIP-1β,
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Fig. 1 Comparison of mRNA expression of five selected inflammatory cytokines between tubal ectopic pregnancy (tEP) oviducts and control, and
the effect of ADM on the expression of these cytokines. (*P < 0.05, Mann–Whitney U test; #P < 0.05, Wilcoxon signed rank test)
Table 1 The effect of ADM treatment on the up-regulated cytokines in tubal ectopic pregnancy (tEP) oviducts (N = 5)
Symbol Protein name tEP vs control tEP + ADM vs tEP
Fold change P value^ Fold change P value#
Pro-inflammatory cytokines
GM-CSF Granulocyte-macrophage colony-stimulating factor 2.5173 0.032* 0.3204 0.032*
IL-7 Interleukin 7 2.5057 0.032* 0.2167 0.043*
IFN-gamma Interferon-gamma 2.1281 0.032* 0.5332 0.080
TNF-beta Tumour necrosis factor-beta 1.8817 0.016* 0.4897 0.043*
Anti-inflammatory cytokines
IL-10 Interleukin 10 1.8760 0.008* 0.6194 0.043*
HGF Hepatocyte growth factor 1.5196 0.032* 0.7346 0.043*
Pro- and anti-inflammatory cytokines
IL-4 Interleukin 4 2.3493 0.032* 0.3941 0.043*
IL-6 Interleukin 6 4.1152 0.016* 0.1135 0.043*
Cytokines which were significantly up-regulated (p < 0.05) in tEP oviducts (N = 5) compared to controls (N = 5) are listed. To study the effect of ADM on the
expression of these up-regulated cytokines, tEP oviducts were treated with 100 nM ADM for 24 h. (*statistically significant, P < 0.05; ^Mann–Whitney U test;
#Wilcoxon signed rank test)
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RANTES, Oncostatin, PDGF-B and NT-3), which were
not significantly upregulated in tEP oviducts compared
to control, were also suppressed by ADM treatment
(Table 2). On the other hand, IL-1α, being not signifi-
cantly altered in tEP compared to control, was signifi-
cantly up-regulated by ADM treatment (p < 0.05).
Discussion
The major risk factors for tEP are tubal damage due to
surgery or infection and smoking [24]. Based on our
pilot study on mRNA expression of five representative
inflammatory cytokines and chemokines, determination
at the protein level was extended to a wider panel of 80
cytokines and chemokines using a commercial antibody
array. We consider studying at the protein level more
important as these are the effector molecules that exert
the final biological and clinical actions. Our results dem-
onstrated significantly higher protein expression of eight
cytokines in the oviducts from tEP patients. These cyto-
kines all play important roles in inflammatory processes.
Most of these are pro-inflammatory although some have
been recognized to have anti-inflammatory properties. It
is the intricate balance the pro- and anti-inflammatory
actions in the local tissue environment that dictates the
ultimate inflammatory process within the tissue. Our re-
sults also showed that ADM treatment was able to re-
verse the up-regulation of most of these proteins in tEP.
Our finding suggests an association between a reduced
ADM expression and an increase in oviductal inflamma-
tory activities in tEP.
Fertilization occurs in the ampullary region of the ovi-
duct. In normal pregnancy, the embryo is transported by
smooth muscle contraction and ciliary beating in the
oviductal lumen [24–26]. Inflammation in the oviduct
affects the tubal transport of embryos by decreasing cil-
iary activity and by increasing surface roughness and
adhesion. For instance, the upregulation of TNFα, a pro-
inflammatory cytokine, following Gonococcal infection
in the oviduct is associated with a decrease of ciliary ac-
tivities [27] and sloughing of ciliated epithelial cells [28].
However, embryo retention in the tubal lumen alone
may not be enough for the establishment of tEP. It has
to be coupled with other local factors favoring tubal im-
plantation [24]. In the context of uterine implantation,
local inflammation initiated by signals from the implant-
ing embryos in the endometrium is required for the es-
tablishment of a receptive endometrium and embryo
adhesion [7]. Pro-inflammatory cytokines including IL-1,
TNF, IL-6 and leukemia inhibitory factor (LIF) in par-
ticular have been detected at the fetal-maternal interface
and are important in implantation [29]. Interestingly all
these cytokines are induced in tubal infection [28, 30, 31].
Therefore, inflammatory activity in the oviduct appears to
predispose the patient to tEP both by impairing tubal
transport of the embryo and by favoring tubal implant-
ation. Chemokines play important roles in both hom-
ing of leukocytes to specific regions within a tissue and
activation of leukocytes. During peri-implantation
period and early pregnancy in humans, the accumula-
tion of leukocytes in the endometrium [32] mediated
by uterine epithelial cells-derived chemokines [33] cre-
ates a local microenvironment permissive to implant-
ation, tissue remodeling and embryo development.
As an additional evidence for the role ADM played in
decreasing the levels of inflammatory cytokines/chemokines
in tEP, our results have demonstrated that exogenous ADM
Table 2 Cytokines/chemokines which were unaltered in tEP oviducts (N = 5) compared to controls (N = 5) but significantly
suppressed by treatment with 100 nM ADM for 24 h
Symbol Protein name Fold change (tEP vs control) Fold change (tEP + ADM vs tEP)
(P > 0.05 for all^) (P < 0.05 for all#)
Pro-inflammatory cytokines
IL-1beta Interleukin 1 beta 1.7201 0.6993*
IL-3 Interleukin 3 1.3484 0.6483*
IL-8 Interleukin 8 1.7410 0.2610*
VEGF Vascular endothelial growth factor 0.9642 0.3234*
Chemokines
GRO-alpha Growth regulated alpha protein 1.6460 0.2310*
MCP-1 C-C motif chemokine 2 1.6450 0.5153*
MIP-1beta C-C motif chemokine 4 1.5562 0.6020*
RANTES C-C motif chemokine 5 1.2964 0.7014*
Oncostatin Oncostatin 1.3642 0.7404*
PDGF-B Platelet-derived growth factor subunit B 0.9040 0.6713*
NT-3 Neurotrophin 3 1.4180 0.7097*
(*statistically significant, P < 0.05; ^Mann–Whitney U test; #Wilcoxon signed rank test)
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abrogated the tEP-associated upregulation of cytokines
(Table 1). Increasing evidence suggests that ADM is an
immunomodulator with both pro-and anti-inflammatory
activities [34]. ADM inhibits cytokine expression or re-
lease in cultured endometrial cells [20]. ADM may switch
off the inflammatory response by regulating innate im-
munity at several critical levels [14] including the reduc-
tion in the production of pro-inflammatory cytokines
such as IFN-gamma [16], TNF-alpha, IL-6 and IL-1 [18]
and various chemokines [19]. The present study has added
to the list several cytokines and chemokines which may
also be regulated by ADM. As ADM expression is gener-
ally reduced in patients with tEP [2], this ADM insuffi-
ciency may result in a tubal environment conducive to
inflammatory activities and tubal implantation, hence con-
tributing to the pathogenesis of tEP.
In our study, we used oviducts removed from non-
pregnant women during hysterectomy as controls. Al-
though these tubal samples were conditioned to a standard
hormonal environment to simulate early pregnancy, it may
be arguable whether it truly represents oviducts during
early intrauterine gestation. However, as oviducts from
normal pregnant women could not possibly be obtained
for ethical reasons, our model is the best practically avail-
able option. Nonetheless, this should not have affected
the main theme of our study on the effect of ADM on
the inflammatory cytokines/chemokines.
To our knowledge, this is the first report on the
immune-modulatory effect of adrenomedullin in the hu-
man oviductal tissue. The main limitation of our study
was the small sample size that we worked on because of
the difficulty in obtaining more samples, which leads to
the pilot nature of this work. Nonetheless, our result
opens up an interesting avenue for further studying the
role of ADM insufficiency in interaction with inflamma-
tory activities in the pathogenesis of tEP.
Conclusions
We report for the first time the down-regulation of some
inflammatory cytokines and chemokines in the tEP
oviducts by ADM. This finding suggests an additional
mechanism whereby ADM insufficiency may increase
the susceptibility to tEP [2], apart from its effects on ciliary
beating and muscle contraction [2] and also fluid secretion
[22]. More studies on the immune-modulatory role of
ADM in the pathogenesis of tEP are warranted.
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